1. Home
  2. EDIT vs GTE Comparison

EDIT vs GTE Comparison

Compare EDIT & GTE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDIT
  • GTE
  • Stock Information
  • Founded
  • EDIT 2013
  • GTE 2003
  • Country
  • EDIT United States
  • GTE Canada
  • Employees
  • EDIT N/A
  • GTE N/A
  • Industry
  • EDIT Biotechnology: Biological Products (No Diagnostic Substances)
  • GTE Oil & Gas Production
  • Sector
  • EDIT Health Care
  • GTE Energy
  • Exchange
  • EDIT Nasdaq
  • GTE Nasdaq
  • Market Cap
  • EDIT 156.5M
  • GTE 178.8M
  • IPO Year
  • EDIT 2016
  • GTE N/A
  • Fundamental
  • Price
  • EDIT $2.25
  • GTE $5.77
  • Analyst Decision
  • EDIT Buy
  • GTE
  • Analyst Count
  • EDIT 13
  • GTE 0
  • Target Price
  • EDIT $6.73
  • GTE N/A
  • AVG Volume (30 Days)
  • EDIT 2.4M
  • GTE 277.0K
  • Earning Date
  • EDIT 08-06-2025
  • GTE 07-30-2025
  • Dividend Yield
  • EDIT N/A
  • GTE N/A
  • EPS Growth
  • EDIT N/A
  • GTE N/A
  • EPS
  • EDIT N/A
  • GTE N/A
  • Revenue
  • EDIT $35,837,000.00
  • GTE $634,805,000.00
  • Revenue This Year
  • EDIT N/A
  • GTE $11.42
  • Revenue Next Year
  • EDIT N/A
  • GTE N/A
  • P/E Ratio
  • EDIT N/A
  • GTE N/A
  • Revenue Growth
  • EDIT N/A
  • GTE N/A
  • 52 Week Low
  • EDIT $0.91
  • GTE $3.34
  • 52 Week High
  • EDIT $6.05
  • GTE $10.40
  • Technical
  • Relative Strength Index (RSI)
  • EDIT 63.76
  • GTE 63.82
  • Support Level
  • EDIT $2.05
  • GTE $4.67
  • Resistance Level
  • EDIT $2.55
  • GTE $6.29
  • Average True Range (ATR)
  • EDIT 0.23
  • GTE 0.30
  • MACD
  • EDIT 0.03
  • GTE 0.11
  • Stochastic Oscillator
  • EDIT 66.29
  • GTE 70.00

About EDIT Editas Medicine Inc.

Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.

About GTE Gran Tierra Energy Inc.

Gran Tierra Energy Inc is an independent energy company. The company, along with its subsidiaries, is focused on oil and gas exploration and production, with assets in Colombia, Canada, and Ecuador. It produces oil, natural gas, and natural gas liquids. Gran Tierra has assembled a diversified, high-quality asset base that is fully operated in Colombia and Ecuador and partly in Canada. The company operates various blocks in Colombia and Ecuador, spanning three basins. It also has contiguous areas in Alberta, Canada, spanning various gross acres across the Western Canadian Sedimentary Basin. The company's reportable segments are Colombia, Ecuador, Canada, and Other. A majority of its revenue is derived from its operations in Colombia.

Share on Social Networks: